The Many Facets Of Early Phase Evaluation Of Psychedelics In Psychiatry

In this webinar the following topics will be covered:

• Regulatory requirements for developing a CNS-active drug and how they apply to psychedelics
• Importance of abuse potential evaluation and the drug scheduling process
• Required preclinical and clinical studies and timelines
• Strategies for early data collection to inform abuse potential, safety, and proof of concept (efficacy)
• Intricacies of handling a Schedule I substance in drug trials